Back to News
Market Impact: 0.25

INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study

Healthcare & BiotechTechnology & InnovationCompany Fundamentals

A study links soluble TNF to the biological pathway between head injury and Alzheimer’s, and shows that selectively neutralizing it with XPro1595 prevents injury-induced increases in amyloid pathology. Treated subjects also demonstrated improved early cognitive performance and pain-related outcomes versus controls. The results are promising but appear preclinical/early-stage based on the wording of the article.

Analysis

A study links soluble TNF to the biological pathway between head injury and Alzheimer’s, and shows that selectively neutralizing it with XPro1595 prevents injury-induced increases in amyloid pathology. Treated subjects also demonstrated improved early cognitive performance and pain-related outcomes versus controls. The results are promising but appear preclinical/early-stage based on the wording of the article.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.45